Novartis, the company now leading the investigational stem cell gene therapy trial for cystinosis, has shared a new community statement. Curious about what’s next? Click here for details.
Novartis, the company now leading the investigational stem cell gene therapy trial for cystinosis, has shared a new community statement. Curious about what’s next? Click here for details.